Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOSE: Dexmedetomidine Opioid Sparing in Ventilated Children
NCT03938857Phase 1Terminated
- Sponsor
- Duke University
- Start
- Jul 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexmedetomidine in critical illness (4 arms), sponsored by Duke University. Primary endpoint: Mean Daily Dose of Fentanyl at Day 7. Started Jul 2019; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT03938857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03938857.